Addition of Tranexamic Acid to the Tactical Combat Casualty Care Guidelines 2011-06
Abstract
Traumatic hemorrhage is the leading cause of preventable death on the battlefield. A comprehensive review of the literature (as provided in this report) found that the antifibrinolytic tranexamic acid (TXA) has proven to decrease all cause mortality following major trauma.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 23, 2011
- Accession Number
- AD1034119